Modification-aware AI enables terminal chemical modifications for peptide design and discovers potent antimicrobials

Antimicrobial resistance (AMR) is an escalating global health threat, intensifying the urgent need for novel antibiotics. Here, we introduce Termini, a generative machine learning (ML) framework that integrates peptide generation, classification, and regression modules to systematically identify potent antimicrobial peptides (AMPs). A key feature of this pipeline is its explicit design of both N- and C-terminal modifications, combined with predictive modeling across 15 bacterial species. We experimentally validated the framework against 11 pathogenic species, representing the broadest spectrum of testing reported to date in such a study. We synthesized and tested 120 peptides (including 60 unique amino acid sequences) with and without terminal modifications. Remarkably, 111 of these peptides (92.5%) demonstrated antimicrobial activity in vitro . Comparative analyses demonstrated that terminal modifications substantially enhanced antimicrobial potency. Furthermore, the lead candidates identified through in vitro screening exhibited robust anti-infective efficacy in subsequent in vivo experiments, confirming their therapeutic potential. Collectively, these results highlight the high hit rate, biological relevance, and translational promise of this integrative, modification-aware AI framework for next-generation antimicrobial peptide development.